Health Condition 1: C800- Disseminated malignant neoplasm, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed cases of carcinoma under Radiotherapy or Chemotherapy or Both, and post radiation participants with symptoms. Those complaining of one or more Adverse effects Such as Nausea, vomiting, Mucositis, Fatigue, Xerostomia, Tastelessness, Skin reaction, Alopecia. Patients who are willing to give informed consent.
Exclusion criteria
Exclusion criteria: Pregnant Or lactating women Patients not willing to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of the therapy of Group A and Group B will be compared before and after treatment by comparing the reduction in the adverse effects of the chemo- radiotherapy , using grades.Timepoint: Study commencement and conduct of the study - 15 Months Outcome Assessment - 3 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety to be assessed by LFT , RFT and haemotological parameters Such as Haemoglobin.Timepoint: Study commencement and conduct of the study - 15 Months Outcome Assessment - 3 Months | — |
Countries
India
Contacts
National Institute of Siddha